They remove the physical burden and cost of travel by delivering medicine directly to the participant's home. This makes it significantly easier for patients, especially those in rural areas, to stay in the study while keeping their daily routines.
Key Takeaways
The Retention Revolution: Travel is a primary reason for the 30% patient dropout rate. Moving the clinical site to the home can remove this significant barrier.
Good Clinical Practice Readiness: While global standards like ICH E6(R3) are evolving, the core principles of Quality by Design are essential for operating in any market, including Myanmar.
Unbroken Chain of Custody: Keeping unapproved medicines stable outside a clinic needs IoT sensors and white-glove delivery, particularly given potential delays during events like the Thingyan Water Festival.
Scalable Compliance: Success in Southeast Asia requires careful management of different medical import licenses and the challenges of reaching remote locations.
Traditional site-centric models of research are facing challenges in 2026. Recruitment goals are often missed because patients cannot manage the time and travel required for visits to central medical facilities. We've built the DHL Health Logistics network to solve this challenge directly. Our 2-billion-euro investment ensures you have the GDP-certified infrastructure and specialised handling needed to reach patients anywhere. Direct-to-Patient (DtP) clinical trials move the laboratory to the living room while keeping the highest levels of safety and compliance.
Why is patient retention the biggest risk in 2026 clinical research?
Travel is a main reason participants leave clinical studies. When you move the trial site to the patient, you reduce missed visits and screen failures, which is especially important in a country with diverse geography like Myanmar.
Travel Distance: Cancer trial patients travel a median of nearly 42 miles for Phase I studies.
Rural Hurdles: Participants in remote areas often travel over 100 miles each way, a significant challenge that can be overcome by delivering supplies directly to them.
Human Connection: Technical couriers act as a professional extension of the clinical site at the doorstep.
Supportive Experience: White-glove services go beyond simple delivery to build participant trust and confidence in the trial process.
DHL Health Logistics provides the professional bridge between your lab and the participant. We understand that a courier is often the only face of the trial that a patient sees and how vital that interaction is.
What are the 2026 regulatory requirements for DtP?
The regulatory environment in Myanmar is evolving. While specific guidelines on decentralised trials are still developing, the principles of Good Clinical Practice (GCP) are paramount. The global shift towards guidelines like ICH E6(R3) means that proving drug stability from the depot to the patient’s home is becoming the standard.
Evolving Standards: Health authorities globally are demanding stronger proof of quality control. This means sponsors must have robust systems in place, regardless of specific local transition timelines.
Strict Accountability: The Myanmar Food and Drug Administration (FDA) requires clear documentation for importing medical products. This means having complete temperature records is a critical part of the import dossier. [Reviewer Note: Please verify current Myanmar FDA guidance on temperature records for clinical trial imports.]
Thermal Protection: Advanced shippers maintain 2 to 8°C or -20°C for up to 120 hours, essential for transit from Yangon Airport to other regions.
Digital Proof: IoT sensors transmit live data to show exactly when a participant received the shipment, providing an undisputable record of the chain of custody.
Our investment in digital tools ensures you have a full thermal audit trail. This transparency is a requirement for satisfying quality assurance teams and navigating regulatory inspections in 2026.
How do you handle medical license restrictions in emerging markets?
Delivering unapproved medicines to a private address is a highly regulated activity that requires careful navigation of local health ministry decrees. You need a partner who understands the specific import requirements in Myanmar.
Health Reforms: The regulatory landscape for healthcare and logistics is subject to change. Staying informed on current decrees is vital for uninterrupted supply chains.
Compliance Scrutiny: All medical and humanitarian shipments must be carefully reviewed against applicable international sanctions frameworks before processing. This is a mandatory step for compliance.
Expert Navigation: Our local specialists in Yangon work with bodies like the Myanmar FDA and the Myanmar Customs Department (MCD) to keep your trial on track. A Licensed Customs Agent with experience in pharmaceuticals is essential.
Expanded Footprint: Proper licensing and compliance allow you to reach regions that were previously considered too complex, enabling more inclusive trial recruitment.
Can you guarantee a secure chain of custody at the doorstep?
Security and privacy are vital when delivering sensitive products to a home. You must ensure the medicine is handed directly to the verified participant or their legal representative, maintaining the integrity of the trial.
Identity Verification: We check IDs against trial records before any package is handed over.
Point-of-Use Delivery: Couriers place the medication directly into the participant’s storage or refrigerator.
Instruction Support: We confirm the patient knows how to handle the packaging and materials.
Safe Disposal: We collect used kits or sharp containers for medical-grade destruction, closing the logistics loop safely.
What is the role of reverse logistics in home-based trials?
A DtP trial does not end at the doorstep. You must also manage the flow of biological samples and unused drugs back to the central lab, often through major hubs like Thilawa Port or Yangon Airport.
Stability Windows: Blood or urine samples must be collected and returned within strict time limits to be viable.
Data Integrity: If a sample gets warm during transit, the trial data is ruined, potentially jeopardising months of research.
Remote Reach: We use specialised Road Transport and air options to reach participants in diverse geographic locations across the country.
Unified Visibility: A clinical research associate in one city should see the same data as a sponsor in another country, thanks to a unified digital platform.
Ready to streamline your clinical trial strategy?
Direct-to-Patient logistics is no longer just a future concept. It’s a practical way to improve the patient experience and protect your data integrity. DHL Health Logistics is ready to help you scale your research across the region with a focus on compliance and care. Speak to a DHL specialist today to check your trial plan and reach your participants with confidence.
Frequently Asked Questions
These 2026 guidelines require sponsors to use a Quality by Design approach. You must have digital proof that your investigational products remain stable and secure throughout the entire journey to the patient, a principle that is important for any market.
We use real-time IoT sensors that transmit live location and thermal data to a central dashboard. This ensures your team receives an immediate alert if the shipment deviates from its required temperature range.
Yes, but success depends on having a partner that understands how to handle the local medical licenses and import regulations in each country. Using a standardised digital platform ensures your quality and compliance data remains comparable across different markets.
Yes, our couriers perform a verified delivery protocol. This includes checking the participant's ID against the trial manifest to ensure the sensitive medication is handed to the correct, authorised person.
Share
Similar Stories
